Rayner & Sophi: A Match Made in Heaven

In January 2024, Rayner, a global leader in ophthalmic solutions, acquired THIS AG, the innovative Swiss manufacturer of the Sophi phacoemulsification machine. In this episode, Prof Paul Ursell, president of UKISCRS in the United Kingdom, engages in an exclusive interview with the CEO of Rayner, and the Vice President of R&D for Sophi and Managing Director of This AG, to explore the details of the acquisition and discuss the future of this collaboration.

 

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner and Sophi are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539